GH Research PLC (GHRS) vs Cyclerion Therapeutics, Inc. (KRSA)
GH Research PLC and Cyclerion Therapeutics, Inc. are both Biotechnology companies. GH Research PLC and Cyclerion Therapeutics, Inc. are of similar size ($1.7B and $1.7B). Across the 10 metrics below, GH Research PLC leads on 6 and Cyclerion Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | GHRS | KRSA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (18.79%) | (98.22%) | (57.72%) |
| Return on assets | (18.16%) | (82.29%) | (49.22%) |
| Return on invested capital | 0.00% | (115.40%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack